Centerbridge Partners - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 53 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Centerbridge Partners ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$3,195
-20.1%
50,0000.0%0.00%
Q3 2022$4,000
-20.0%
50,0000.0%0.00%
Q2 2022$5,000
-58.3%
50,0000.0%0.00%
-100.0%
Q1 2022$12,000
-63.6%
50,0000.0%0.00%
-50.0%
Q4 2021$33,0000.0%50,0000.0%0.00%
-50.0%
Q3 2021$33,000
-23.3%
50,0000.0%0.00%0.0%
Q2 2021$43,000
+43.3%
50,0000.0%0.00%
+33.3%
Q1 2021$30,00050,0000.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q4 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 202,950$2,009,0000.05%
Kingstown Capital 300,000$27,0000.04%
RAMIUS ADVISORS LLC 567,986$51,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 88,875$880,0000.02%
Q Global Advisors, LLC 300,000$27,0000.02%
MARSHALL WACE, LLP 575,000$5,693,0000.01%
HGC Investment Management Inc. 2,443,365$403,0000.01%
Corbin Capital Partners, L.P. 464,062$42,0000.01%
LMR Partners LLP 50,000$495,0000.01%
Telemetry Investments, L.L.C. 153,694$6,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders